Impact on Cardiac Toxicity With Trastuzumab and Radiotherapy: The Question Is Still Ongoing

被引：10
|
作者：
Magne, Nicolas [1 ]
Vedrine, Lionel [2 ]
Chargari, Cyrus [3 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Med Oncol, Paris, France
[2] Hop Instruct Armees Val de Grace, Dept Med Oncol, Paris, France
[3] Hop Instruct Armees Val de Grace, Dept Radiotherapy, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 34期
关键词：
D O I：
10.1200/JCO.2009.24.6918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E239 / E239
页数：1
相关论文
共 50 条
  • [41] SEQUENTIAL RADIOTHERAPY AND ADRIAMYCIN IN THE MANAGEMENT OF BRONCHOGENIC CARCINOMA - QUESTION OF ADDITIVE TOXICITY
    RUCKDESCHEL, JC
    BAXTER, DH
    MCKNEALLY, MF
    KILLAM, DA
    LUNIA, SL
    HORTON, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (08): : 1323 - 1328
  • [42] Cardiac toxicity of mediastinal radiotherapy: Which are the critical structures?
    Vordermark, D
    Seufert, I
    Schwab, F
    Flentje, M
    Kung, M
    Angermann, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3634 - 3636
  • [43] The impact of spironolactone on the lung injury induced by concomitant trastuzumab and thoracic radiotherapy
    Yavas, G.
    Yavas, C.
    Celik, E.
    Sen, E.
    Ata, O.
    Afsar, R. E.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2019, 17 (01): : 87 - 95
  • [44] The impact of chemotherapy on toxicity in the era of hypofractionated radiotherapy
    De Santis, M. C.
    Di Salvo, F.
    Bonfantini, F.
    Dispinzieri, M.
    Franceschini, M.
    Soncini, F.
    Mantero, E. D.
    Cosentino, V.
    Poste, D.
    Baili, P.
    Sant, M.
    Pignoli, E.
    Lozza, L.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S242 - S243
  • [45] New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab
    Nack, Elana
    Koffer, Paul P.
    Blumberg, Charles S.
    Leonard, Kara Lynne
    Huber, Kathryn E.
    Fenton, Mary Anne
    Dizon, Don S.
    Wazer, David E.
    Hepel, Jaroslaw T.
    CLINICAL BREAST CANCER, 2020, 20 (03) : 246 - 252
  • [46] The Impact of Spironolactone on the Lung Injury Induced by Concomitant Trastuzumab and Thoracic Radiotherapy
    Yavas, G.
    Yavas, C.
    Celik, E.
    Sen, E.
    Ata, O.
    Yuce, D.
    Elsurer-Afsar, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S638 - S638
  • [47] Cardiac resynchronization therapy and atrial tachyarrhythmias: A question still searching for an answer
    Adelstein, Evan
    Saba, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (06) : 676 - 677
  • [48] ASSESSMENT OF MARKERS OF CARDIAC TOXICITY FOLLOWING COMBINED TREATMENT OF CARDIOMYOCYTES WITH EPIRUBICIN AND TRASTUZUMAB
    Bell, David
    Tonry, Claire
    Donncha, Eimear Mhic
    Scott, Hannah
    Harbinson, Mark
    Watson, Chris J.
    HEART, 2020, 106 : A7 - A8
  • [49] The value of routine trastuzumab-related cardiac toxicity monitoring in gastrointestinal cancers
    Kosydar, Samual R.
    Castrichini, Matteo
    Zhu, Mojun
    Xie, Hao
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Incidence, Diagnosis, and Treatment of Cardiac Toxicity From Trastuzumab in Patients With Breast Cancer
    Nowsheen S.
    Viscuse P.V.
    O’Sullivan C.C.
    Sandhu N.P.
    Haddad T.C.
    Blaes A.
    Klemp J.
    Nhola L.
    Herrmann J.
    Ruddy K.J.
    Current Breast Cancer Reports, 2017, 9 (3) : 173 - 182
12345